- Home
- TSSI vs TIL Comparison
TSSI vs TIL Comparison
Compare TSSI & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSSI
- TIL
- Stock Information
- Founded
- TSSI N/A
- TIL 2018
- Country
- TSSI United States
- TIL United States
- Employees
- TSSI N/A
- TIL N/A
- Industry
- TSSI Professional Services
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- TSSI Consumer Discretionary
- TIL Health Care
- Exchange
- TSSI Nasdaq
- TIL Nasdaq
- Market Cap
- TSSI 214.7M
- TIL 218.4M
- IPO Year
- TSSI N/A
- TIL 2021
- Fundamental
- Price
- TSSI N/A
- TIL $26.50
- Analyst Decision
- TSSI
- TIL Buy
- Analyst Count
- TSSI 0
- TIL 4
- Target Price
- TSSI N/A
- TIL $100.33
- AVG Volume (30 Days)
- TSSI N/A
- TIL 154.7K
- Earning Date
- TSSI N/A
- TIL 11-13-2024
- Dividend Yield
- TSSI N/A
- TIL N/A
- EPS Growth
- TSSI N/A
- TIL N/A
- EPS
- TSSI N/A
- TIL N/A
- Revenue
- TSSI N/A
- TIL N/A
- Revenue This Year
- TSSI N/A
- TIL N/A
- Revenue Next Year
- TSSI N/A
- TIL $2.64
- P/E Ratio
- TSSI N/A
- TIL N/A
- Revenue Growth
- TSSI N/A
- TIL N/A
- 52 Week Low
- TSSI N/A
- TIL $6.08
- 52 Week High
- TSSI N/A
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- TSSI N/A
- TIL 38.29
- Support Level
- TSSI N/A
- TIL $24.31
- Resistance Level
- TSSI N/A
- TIL $37.24
- Average True Range (ATR)
- TSSI 0.00
- TIL 4.02
- MACD
- TSSI 0.00
- TIL 0.26
- Stochastic Oscillator
- TSSI 0.00
- TIL 10.85
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.